BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Herrema H, Nieuwdorp M, Groen AK. Microbiome and Cardiovascular Disease. Berlin: Springer Berlin Heidelberg; 2020. [DOI: 10.1007/164_2020_356] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Israr MZ, Zhan H, Salzano A, Voors AA, Cleland JG, Anker SD, Metra M, van Veldhuisen DJ, Lang CC, Zannad F, Samani NJ, Ng LL, Suzuki T; BIOSTAT-CHF investigators (full author list as appendix). Surrogate markers of gut dysfunction are related to heart failure severity and outcome-from the BIOSTAT-CHF consortium. Am Heart J 2022;248:108-19. [PMID: 35278373 DOI: 10.1016/j.ahj.2022.03.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Berthelot JM, Bandiaky ON, Le Goff B, Amador G, Chaux AG, Soueidan A, Denis F. Another Look at the Contribution of Oral Microbiota to the Pathogenesis of Rheumatoid Arthritis: A Narrative Review. Microorganisms 2021;10:59. [PMID: 35056507 DOI: 10.3390/microorganisms10010059] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
3 Laffin LJ, Bakris GL. Intersection Between Chronic Kidney Disease and Cardiovascular Disease. Curr Cardiol Rep 2021;23:117. [PMID: 34269921 DOI: 10.1007/s11886-021-01546-8] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
4 Almeida C, Barata P, Fernandes R. The influence of gut microbiota in cardiovascular diseases-a brief review. Porto Biomed J 2021;6:e106. [PMID: 33490701 DOI: 10.1097/j.pbj.0000000000000106] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
5 Kirichenko TV, Markina YV, Sukhorukov VN, Khotina VA, Wu WK, Orekhov AN. A Novel Insight at Atherogenesis: The Role of Microbiome. Front Cell Dev Biol 2020;8:586189. [PMID: 33072766 DOI: 10.3389/fcell.2020.586189] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]